Skip Navigation


Glycobiology Advance Access originally published online on October 31, 2007
Glycobiology 2008 18(1):74-83; doi:10.1093/glycob/cwm118
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/1/74    most recent
cwm118v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Itoh, Y.
Right arrow Articles by Irimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, Y.
Right arrow Articles by Irimura, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Identification and Expression of Human Epiglycanin/MUC21: a Novel Transmembrane Mucin*

Yuichi Itoh3,4, Mika Kamata-Sakurai3,4, Kaori Denda-Nagai4, Shigenori Nagai5, Makoto Tsuiji4, Katrin Ishii-Schrade4, Kyoko Okada4, Akiteru Goto6, Masashi Fukayama6 and Tatsuro Irimura1,2,4

4 Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences
5 Department of Molecular Preventive Medicine, Graduate School of Medicine
6 Department of Pathology, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan

1 To whom correspondence should be addressed: Tel: +81-3-5841-4870; Fax +81-3-5841-4879; e-mail: irimura{at}mol.f.u-tokyo.ac.jp

Received on July 31, 2007; revised on September 14, 2007; accepted on October 15, 2007

The gene for the human orthologue of mouse epiglycanin, a mucin expressed on mammary carcinoma TA3-Ha cells but not TA3-St cells, was identified by homology search to a mouse epiglycanin cDNA fragment identified by representational difference analysis between TA3-Ha and TA3-St cells. The open reading frame of this gene was cloned from human cervical carcinoma ME-180 cells. It consists of a mucin domain with 28 nonidentical tandem repeats of 45 nucleotides each corresponding to a threonine/serine-rich peptide, a stem domain, a transmembrane domain, and a cytoplasmic tail. The cloned cDNA with a FLAG sequence was expressed in K562 cells. A combination of immunoprecipitation with a polyclonal antibody specific for the cytoplasmic tail and Western blotting analysis with an anti-FLAG antibody and lectins revealed a mucin-like component as the gene product. Analysis by the use of tissue cDNA libraries indicated that the gene is expressed in lung, large intestine, thymus, and testis among 16 normal tissues tested. The polyclonal antibody specific for a synthetic peptide from the cytoplasmic tail, when tested for its reactivity with normal lung tissues, reacted with epithelia of bronchi and bronchioli but not with alveoli. All of 24 lung adenocarcinomas specimens tested were reactive with the antibody, whereas reactivity was observed with only 2 out of 24 squamous and none out of 24 small cell lung carcinomas. This is a novel transmembrane mucin and designated as MUC21.

Key words: cDNA cloning / epiglycanin / lung carcinoma / mucin

* The nucleotide sequences reported in this paper have been submitted to the DDBJ/GenBank/EBI Deta Bank with the accession numbers AB242595 for human epiglycanin/MUC21 cDNA and AB242596 for mouse epiglycanin/ Muc21 cDNA.

2 Present address: Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033, Japan.

3 These authors equally contributed to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.